Regional Cancer Center At Faxton Hospital is categorized under Hospitals in Utica, NY and active since 1994.
Regional Cancer Center At Faxton Hospital was established in 1994, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 622110 by the NAICS.
If you are seeking more information, feel free to contact Lucille Rotundo at the company’s single location by writing to 1676 Sunset Avenue, Utica, New York NY 13502 or by phoning (315) 624-4411. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Regional Cancer Center At Faxton Hospital |
| Contact Person: | Lucille Rotundo |
| Address: | 1676 Sunset Avenue, Utica, New York 13502 |
| Phone Number: | (315) 624-4411 |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 1994 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospitals |
| SIC Code: | 8062 |
| NAICS Code: | 622110 |
| Share This Business: |
Regional Cancer Center At Faxton Hospital was started in 1994 to provide professional Hospitals under the SIC code 8062 and NAICS code 622110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Lucille Rotundo for inquiries that concern Regional Cancer Center At Faxton Hospital by calling the company number (315) 624-4411, as your correspondence is most welcome. Additionally, the physical location of the single location of Regional Cancer Center At Faxton Hospital can be found at the coordinates 43.090588,-75.258267 as well as the street address 1676 Sunset Avenue in Utica, New York 13502.
For its online presence, you may visit Regional Cancer Center At Faxton Hospital’s website at and engage with its social media outlets through on Twitter and on Facebook.